文献速递头颈外科

头颈癌手术中的抗生素预防:系统评价与贝叶斯网络Meta分析

Antibiotic prophylaxis in head and neck cancer surgery: Systematic review and Bayesian network meta-analysis.
PubMed 文献 · Head Neck · 2021-11-06

该系统评价与贝叶斯网络Meta分析纳入20项研究共8627例头颈癌手术患者,间接比较不同抗生素预防手术部位感染(SSI)的效果。与克林霉素短疗程相比,青霉素类和头孢菌素类多种方案可降低SSI风险;克林霉素与无抗生素之间无显著差异;长疗程较短疗程无优势。作者认为青霉素类和头孢菌素类是最佳选择,克林霉素对青霉素过敏者似乎无效,需进一步研究。

要点

  • 与克林霉素短疗程相比,氨苄西林/舒巴坦或其他青霉素短疗程(OR 0.37)、头孢唑林(OR 0.36)等可降低SSI风险。
  • 克林霉素与无抗生素之间SSI风险无显著差异(OR 2.3,95%CrI 0.59-9.9)。
  • 长疗程预防较短疗程无额外优势;青霉素过敏者使用克林霉素似乎无效,需进一步研究。

核心结论

  • 抗生素预防在头颈癌手术中预防SSI具有重要作用,当前证据提示青霉素类和头孢菌素类是最佳选择。
  • 长疗程预防较短疗程无任何优势。
  • 对标注为青霉素过敏的患者,克林霉素似乎无效,需进一步研究以提供更好的治疗。

研究设计与样本

  • 系统评价与贝叶斯网络Meta分析,遵循PRISMA-NMA清单。
  • 纳入标准为回顾性或前瞻性设计、招募任何亚部位头颈肿瘤的成年患者、比较不同抗生素或不同抗生素疗程、样本量超过10例的研究。
  • 共检索到310条引文,排除250条后对60篇全文审查,最终纳入20篇文献进行数据提取和分析。
  • 纳入研究共评估8627例患者。

主要发现

  • 与克林霉素短疗程相比,氨苄西林/舒巴坦或其他青霉素短疗程OR为0.37(95%CrI 0.19-0.72)。
  • 与克林霉素短疗程相比,头孢唑林/甲硝唑短疗程OR为0.26(95%CrI 0.06-0.93),头孢唑林OR为0.36(95%CrI 0.17-0.79)。
  • 与克林霉素短疗程相比,氨苄西林/舒巴坦长疗程OR为0.20(95%CrI 0.04-0.91),头孢唑林/甲硝唑长疗程OR为0.27(95%CrI 0.09-0.64)。
  • 与克林霉素短疗程相比,头孢哌酮OR为0.05(95%CrI 0.002-0.89),头孢噻肟OR为0.04(95%CrI 0.002-0.85)。

关键数值与推荐

  • 与克林霉素短疗程相比,氨苄西林/舒巴坦或其他青霉素短疗程OR 0.37(95%CrI 0.19-0.72)。
  • 与克林霉素短疗程相比,头孢唑林/甲硝唑短疗程OR 0.26(95%CrI 0.06-0.93),头孢唑林OR 0.36(95%CrI 0.17-0.79)。
  • 与克林霉素短疗程相比,氨苄西林/舒巴坦长疗程OR 0.20(95%CrI 0.04-0.91),头孢唑林/甲硝唑长疗程OR 0.27(95%CrI 0.09-0.64)。
  • 与克林霉素短疗程相比,头孢哌酮OR 0.05(95%CrI 0.002-0.89),头孢噻肟OR 0.04(95%CrI 0.002-0.85)。

临床怎么用

  • 作者认为,青霉素类和头孢菌素类是头颈癌手术SSI预防的最佳选择。
  • 作者认为,长疗程预防较短疗程无任何优势。
  • 作者指出,对标注为青霉素过敏的患者使用克林霉素似乎无效,需进一步研究以改善该亚组患者的治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Postoperative surgical site infections (SSI) are worrisome complications after head and neck cancer surgery. Due to the lack of direct comparisons, it is difficult to indicate the best antibiotic in the setting of SSI prophylaxis for patients with head and neck cancer. For this reason, we decided to conduct a Bayesian network meta-analysis of clinical studies evaluating various antibiotic classes for SSI prophylaxis; thus, we directly and indirectly compared all the available antibiotics in the setting of head and neck oncological surgery. We performed a systematic review and a network meta-analysis according to the PRISMA-NMA checklist. Regarding inclusion criteria, we included articles with retrospective or prospective design recruiting adult participants with head and neck neoplasm of any subsite that compared different antibiotics or that compared different antibiotic treatment duration with sample sizes of more than 10 patients. Overall, 310 citations were identified by the search on all databases. Of these, 250 were excluded based on title and abstract, leaving 60 publications for full text examination. Finally, 20 papers were included for data extraction and analysis. In total, 8627 patients were evaluated across the included studies. Results of the Bayesian network meta-analysis showed that when compared to clindamycin short course, the antibiotics effective in preventing SSI were ampicillin/sulbactam or other penicillin short course (OR: 0.37, 95%CrI: 0.19-0.72), cefazolin/metronidazole short course (OR: 0.26, 95%CrI: 0.06-0.93), cefazolin (OR: 0.36, 95%CrI: 0.17-0.79), ampicillin/sulbactam long course (OR: 0.20, 95%CrI: 0.04-0.91), cefazolin/metronidazole long course (OR: 0.27, 95%CrI: 0.09-0.64), cefoperazone (OR: 0.05, 95%CrI: 0.002-0.89), cefotaxime (OR: 0.04, 95%CrI: 0.002-0.85). There was no significant difference between clindamycin and no antibiotic (OR: 2.3, 95%CrI: 0.59-9.9). Clindamycin plus aminoglycoside seemed to give a slight protection from SSI compared to clindamycin alone (OR: 0.30, 95%CrI: 0.09-0.99) or no antibiotic (OR: 0.13, 95%CrI: 0.02-067). Antibiotic prophylaxis is important in preventing SSI in head and neck cancer setting. Current evidence suggests that penicillins and cephalosporins are the best choice. Moreover, long duration course does not give any advantage compared to short course prophylaxis. Finally, it is important to implement appropriate antibiotic prophylaxis in patients that are labeled as penicillin allergic, in this regard clindamycin seems to be ineffective and, for this reason, further research is needed to provide a better care for this subset of patients.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Iocca O, Copelli C, Ramieri G, et al. Antibiotic prophylaxis in head and neck cancer surgery: Systematic review and Bayesian network meta-analysis. Head Neck. 2021. PMID: 34741354. doi:10.1002/hed.26908

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。